Spinal and peripheral adenosine A1 receptors contribute to antinociception by tramadol in the formalin test in mice

European Journal of Pharmacology

Volumn 714, Issue 1-3, 2013, Pages 373-378

  Sawynok, Jana ^a   Reid, Allison R ^a   Liu, Jean ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Adenosine; Formalin; Tramadol

Indexed keywords

3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; CAFFEINE; FORMALDEHYDE; SEROTONIN 7 RECEPTOR; TRAMADOL;

ANALGESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG SELECTIVITY; INHIBITION KINETICS; LUMBAR PUNCTURE; MALE; MOUSE; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL;

ADENOSINE; FORMALIN; TRAMADOL;

ANALGESICS; ANIMALS; HINDLIMB; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED C57BL; PAIN MEASUREMENT; RECEPTOR, ADENOSINE A1; SPINE; TRAMADOL;

EID: 84885480886     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.07.012     Document Type: Article

References (44)

1. Aley, K.O., Green, P.G., Levine, J.D., 1995. Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal. J. Neurosci. 15, 8031-8038.
2. 3 spinal receptor involvement in acute pain in humans. Anesth. Analg. 94, 1553-1557. (Pubitemid 34556642)
3. 1A and opioid receptors in the antiallodynic effect of tramadol in the chronic constriction injury model of neuropathic pain in rats. Psychopharmacology 193, 97-105. (Pubitemid 46906628)
4. Bráz, J.M., Basbaum, A.I., 2010. Differential ATF3 expression in dorsal root ganglion neurons reveal the profile of primary afferents engaged by diverse noxious chemical stimuli. Pain 150, 290-301.
5. Cahill, C.M., White, T.D., Sawynok, J., 1995. Spinal opioid receptors and adenosine release: neurochemical and behavioural characterization of opioid receptor subtypes. J. Pharmacol. Exp. Ther. 275, 84-93.
6. Dhillon, S., 2010. Tramadol/paracetamol fixed dose combination. Clin. Drug Invest. 30, 711-738.
7. Díaz-Reval, M.I., Carillo-Munguía, N., Martínez- Casas, M., González-Trujano, M.E., 2010. Tramadol and caffeine produce synergistic interactions on antinociception measured in a formalin model. Pharmacol. Biochem. Behav. 97, 357-362.
8. 7 receptors. Eur. J. Pharmacol. 677, 93-101.
9. 7 receptor in rat dorsal spinal cord: immunohistochemical evidence. J. Comp. Neurol. 490, 256-269. (Pubitemid 41140992)
10. Goldman, N., Chen, M., Fujita, T., Xu, Q., Liu, W., Jensen, T.K., Pei, Y., Wang, F., Han, X., Chen, J.F., Schnermann, J., Takano, T., Bekar, L., Tieu, K., Nedergaard, M., 2010. Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture. Nat. Neurosci. 13. (883-839).
11. Grond, S., Sablotzki, A., 2004. Clinical pharmacology of tramadol. Clin. Pharmaco-kinet. 43, 879-923. (Pubitemid 39447033)
12. Haeseler, G., Foadi, N., Ahrens, J., Dengler, R., Hecker, H., Leuwer, M., 2006. Tramadol, fentanyl and sufentanil but not morphine block voltage-operated sodium channels. Pain 126, 234-244. (Pubitemid 44751970)
13. 7 receptor antagonist. Br. J. Pharmacol. 130, 539-548. (Pubitemid 30332971)
14. Hama, A., Sagen, J., 2007. Altered antinociceptive efficacy of tramadol over time in rats with painful peripheral neuropathy. Eur. J. Pharmacol. 559, 32-37. (Pubitemid 46274643)
15. Hara, K., Minami, K., Sata, T., 2005. The effects of tramadol and its metabolite on glycine, gamma-aminobutyric acidA, and N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Anesth. Analg. 100, 1400-1405. (Pubitemid 40577394)
16. Hurt, J.K., Zylka, M.J., 2012. PAPupuncture has localized and long-lasting antinoci-ceptive effects in mouse models of acute and chronic pain. Mol. Pain 8, 28.
17. Ide, S., Minami, M., Ishihara, K., Uhl, G.R., Sora, I., Ikeda, K., 2006. Mu opioid receptor-dependent and independent components in effects of tramadol. Neuropharmacology 51, 651-658. (Pubitemid 44215970)
18. Jesse, C.R., Nogueira, C.W., 2010. Evidence for the involvement of glutamatergic and neurokinin 1 receptors in the antinociception elicited by tramadol in mice. Pharmacology 85, 36-40.
19. Kayser, V., Besson, J.M., Guilbaud, G., 1992. Evidence for a noradrenergic component in the antinociceptive effect of the analgesic agent tramadol in an animal model of clinical pain, the arthritic rat. Eur. J. Pharmacol. 224, 83-88.
20. Li, C, Chen, S.Q., Chen, B.X., Huang, W.Q., Liu, K.X., 2012. The antinociceptive effect of intrathecal tramadol in rats: the role of alpha 2-adrenoceptors in the spinal cord. J. Anesth. 26, 230-235.
21. Lima, FO., Souza, G.R., Verri, W.A., Parada, CA., Ferreira, S.H., Cunha, F.Q., and Cunha., T. M., 2010. Direct blockade of inflammatory hypernociception by peripheral A1 adenosine receptors: involvement of the NO/cGMP/PKG/KATP signaling pathway. Pain 151, 506-515.
22. 7 and adenosine A1 receptors, as well as peripheral adenosine A1 receptors, are involved in antinociception by systemic administration of amitriptyline. Eur. J. Pharmacol. 698, 213-219.
23. 7 and adenosine A1 receptors in the spinal cord and adenosine A1 receptors in the periphery. Neurosci. Lett. 536, 64-68.
24. Marincsák, R., Toth, B.I., Czifra, G., Szabó, T., Kovács, L., Bíró, T., 2008. The analgesic drug, tramadol, acts as an agonist of the transient receptor potential vanilloid-1. Anesth. Analg. 106, 1890-1896.
25. Mert, T., Gunes, Y., Gunay, I., 2007. Local analgesic efficacy of tramadol following intraplantar injection. Eur. J. Pharmacol. 558, 68-72. (Pubitemid 46328871)
26. Nakajima, K., Obata, H., Ito, N., Goto, F., Saito, S., 2009. The nociceptive mechanism of 5-hydroxytryptamine released into the peripheral tissue in acute inflammatory pain in rats. Eur. J. Pharmacol. 13, 441-447.
27. Nogatomo, K., Kubo, Y., 2008. Caffeine activates mouse TRPA1 channels but suppresses human TRPA1 channels. Proc. Natl. Acad. Sci. USA 105, 17373-17378.
28. Pozos-Guillén, A.J., Aguirre-Bañueldo, P., Arellano-Guerrero, A., Castañada-Hernández, G., Hoyo-Vadillo, C, Pérez-Urizar, J., 2006. Isobolographic analysis of the dual-site synergism in the antinociceptive response of tramadol in the formalin test in rats. Life Sci. 79, 2275-2282. (Pubitemid 44666068)
29. Raffa, R.B., Friderichs, E., Reimann, W., Shank, R.P., Codd, E.E., Vaught, J.L, 1992. Opioid and non-opioid components independently contribute to the mechanism of action of tramadol, an "atypical," opioid analgesic. J. Pharmacol. Exp. Ther. 260, 275-285.
30. Raffa, R.B., Friderichs, E., Reimann, W., Shank, R.P., Codd, EE., Vaught, J.L., and Jacoby., H. I., Selve, N., 1993. Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. J. Pharmacol. Exp. Ther. 267, 331-340. (Pubitemid 23325025)
31. Rittiner, J.E., Korboukh, I., Hull-Ryde, EA., Jin, J., Janzen, W.P., Frye, S.V., Zylka, M.J., 2012. AMP is an adenosine A1 receptor agonist. J. Biol. Chem. 287, 5301-5309.
32. 7 receptors in the formalin test. Pain 117, 182-192. (Pubitemid 41764786)
33. 7) activating cAMP formation. Proc. Natl. Acad. Sci. USA 90, 8547-8551. (Pubitemid 23277706)
34. Sawynok, J., 2013. Adenosine and Pain. In: Masino, S., Boison, D. (Eds.), Adenosine A Key Link Between Metabolism and Central Nervous System Activity. Springer, NY, pp. 343-360.
35. Sawynok, J., Liu, X.J., 2004. The formalin test: characteristics and usefulness of the model. Rev. Analg. 7, 145-163.
36. Sawynok, J., Liu, X.J., 2003. Adenosine in the spinal cord and periphery: release and regulation of pain. Prog. Neurobiol. 69, 313-340. (Pubitemid 36645052)
37. 2 receptors. Eur. J. Pharmacol. 298, 105-111. (Pubitemid 26080309)
38. Sawynok, J., Reid, A.R., 2012. Caffeine inhibits antinociception by acetaminophen in the formalin test by inhibiting spinal adenosine A1 receptors. Eur. J. Pharmacol. 674, 248-254.
39. Sowa, N.A., Street, S.E., Vihko, P., Zylka, M.J., 2010. Prostatic acid phosphatase reduces thermal sensitivity and chronic pain sensitization by depleting phos-phatidylinositol 4,5-bisphospate. J. Neurosci. 30, 10282-10293.
40. Sweeney, M.I., White, T.D., Sawynok, J., 1990. 5-Hydroxytryptamine releases adenosine and cyclic AMP from primary afferent nerve terminals in the spinal cord in vivo. Brain Res. 528, 55-61. (Pubitemid 20292937)
41. Wang, J.T.C., Chung, C.C.W., Whitehead, R.A., Schwarz, S.K.W., Ries, CR., MacLeod, B. A., 2010. Effects of local tramadol administration on peripheral glutamate-induced nociceptive behaviour in mice. Can. J. Anesth. 57, 659-663.
42. Xie, H., Dong, Z.Q., Ma, F., Bauer, W.R., Wang, X., Wu, G.C, 2008. Involvement of serotonin 2A receptors in the analgesic effect of tramadol in mono-arthritic rats. Brain Res. 1210, 76-83.
43. 7 receptors play an important role in the antinociceptive and antihyperalgesic effects of tramadol and its metabolite, O-desmethyltramadol, via activation of descending serotonergic pathways. Anesthesiology 112, 696-710.
44. Zylka, M.J., 2011. Pain-relieving prospects for adenosine receptors and ectonucleo-tidases. Trends Molec. Med. 17, 188-196.